2011-11-15T09:59:38-06:00 2010-12-31 COUNCILOR BUCHANAN & MITCHELL PC 7910 WOODMONT AVENUE SUITE 500 BETHESDA MD 20814 990 2010-01-01 222432063 INTERNATIONAL SOCIETY FOR THE STUDY OF XENOBIOTICS INTE 2023671160 2025 M STREET NW NO 800 WASHINGTON DC 20036 STEVE KEMP 2023671160 2011-11-09 1 DANIEL L WEAVER 3019860600 2010 2016-02-24 21:20:13Z STEVE KEMP 2025 M STREET NW NO 800 WASHINGTON DC 20036 1890190 0 X WWW.ISSX.ORG X 1981 DC ASSOCIATION OF INTERNATIONAL SCIENTISTS ENGAGED IN RESEARCH IN XENOBIOTIC METABOLISM. 14 14 0 25 23380 -100 104929 98100 1232915 726909 -28313 95955 49829 35930 1359360 956894 18890 10000 0 0 0 0 0 0 0 1480819 1183710 1499709 1193710 -140349 -236816 1799089 1579400 157377 152797 1641712 1426603 ISSX IS AN INTERNATIONAL SOCIETY WHICH FACILITATES AND ENCOURAGES THE ASSEMBLAGE, ACQUAINTANCESHIP, AND THE ASSOCIATION OF SCIENTISTS ENGAGED IN RESEARCH IN XENOBIOTIC METABOLISM AND IN OTHER RELATED DISCIPLINES. 0 0 757900 634236 SCIENTIFIC MEETINGS - ISSX SPONSORS DOMESTIC AND INTERNATIONAL SCIENTIFIC MEETINGS TO BRING TOGETHER RESEARCHERS FOR INSTRUCTION IN AND EXCHANGE OF SCIENTIFIC KNOWLEDGE IN THE FIELD OF XENOBIOTICS. ISSX HOSTS THE INTERNATIONAL MEETING, ONE OF THE WORLD'S LARGEST GATHERINGS OF RESEARCHERS IN XENOBIOTICS, OFFERING INNOVATIVE SHORT COURSES, SYMPOSIA, LECTURES AND OTHER EVENTS. ISSX ALSO HOSTS REGIONAL MEETINGS AND WORKSHOPS IN ASIA-PACIFIC, EUROPE, AND NORTH AMERICA ON A REGULAR BASIS. 46628 14700 NEWSLETTER - PROVIDE FOR THE EXCHANGE OF INFORMATION BETWEEN SCIENTISTS AND INFORM MEMBERS OF EDUCATIONAL OPPORTUNITIES AND NEWS IN THE FIELD OF XENOBIOTICS. OFFERS OPPORTUNITIES FOR PROFESSIONAL EXPOSURE THROUGH SOLICITATION AND PUBLICATION OF ABSTRACTS AND POSTER PRESENTATIONS. 43238 19682 OTHER PROGRAMS - AWARD PROGRAMS AND OTHER ACTIVITIES TO PROMOTE RESEARCH AND DISSEMINATION OF THE INFORMATION ABOUT XENOBIOTICS. ISSX AWARDS RECOGNITION OF EXCELLENCE IN SCIENTIFIC AND SERVICE ACHIEVEMENTS THROUGH THE INTERNATIONAL DISTINGUISHED SCIENTIFIC ACHIEVEMENT AND DISTINGUISHED SERVICE AWARDS, AND THE REGIONAL SCIENTIFIC AND NEW INVESTIGATOR AWARDS. 847766 1 1 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 0 1 1 0 0 0 0 0 0 0 0 0 X 14 14 0 1 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 0 0 0 DC X SMITHBUCKLIN CORPORATION 2023671160 2025 M STREET NW NO 800 WASHINGTON DC 20036 X URS MEYER 4.00 X X 0 0 0 BILL SMITH 4.00 X X 0 0 0 JOHN MINERS 4.00 X X 0 0 0 ERIC JOHNSON 2.00 X X 0 0 0 CHARLES CRESPI 1.00 X X 0 0 0 PHILIP BOARD 1.00 X 0 0 0 CHANTAL GUILLEMETTE 1.00 X 0 0 0 KATHIE KNIGHTS 1.00 X 0 0 0 BRIAN HOUSTON 1.00 X 0 0 0 YASUSHI YAMAZOE 1.00 X 0 0 0 PAUL HOLLENBERG 1.00 X 0 0 0 IKUMI TAMAI 1.00 X 0 0 0 LASZLO VERECZKEY 1.00 X 0 0 0 STELVIO BANDIERA 1.00 X 0 0 0 STEVE KEMP 20.00 X 0 0 0 0 0 0 0 0 0 0 SMITHBUCKLIN CORPORATION 2025 M STREET NW SUITE 800 WASHINGTON DC 20036 MANAGEMENT SERVICES 481858 1 98100 98100 CONFERENCES AND MEETIN 900099 496881 496881 MEMBERSHIP DUES 900099 135153 135153 POLYMORPHISM WORKSHOP 900099 94875 94875 726909 50056 50056 979195 933296 45899 45899 45899 ADVERTISING 541800 14700 14700 WEBSITE ADVERTISING 541800 8680 8680 MISCELLANEOUS 900099 7050 7050 5500 5500 35930 956894 733959 23380 101455 10000 10000 297394 92119 205275 36755 36755 14261 4536 9725 140881 140881 4022 4022 81010 77945 3065 41673 33283 8390 431930 425939 5991 11400 5671 5729 PRESIDENT'S FUND 32363 9299 23064 CREDIT CARD AND BANK FE 21221 21221 OTHER BUSINESS FEES AND 18521 17829 692 COUNCIL AND COMMITTEES 17956 17956 MISCELLANEOUS 13121 10564 2557 21202 15678 5524 1193710 847766 345944 0 86967 72557 36363 20585 15528 140685 23425 1514489 1467890 1799089 1579400 45386 35267 111991 117530 157377 152797 X 1350089 1117998 251623 268605 40000 40000 1641712 1426603 1799089 1579400 X -236816 21707 X X 0 1 1 X 0 X 326359 375684 274805 260773 233253 1470874 1152671 783829 1417623 1071802 591756 5017681 1479030 1159513 1692428 1332575 825009 6488555 0 21922 6509 5975 16858 51264 21922 6509 5975 16858 51264 6437291 67660 66249 52512 65318 50056 301795 67660 66249 52512 65318 50056 301795 6149 3101 1451 4607 7050 22358 1552839 1228863 1746391 1402500 882115 6812708 0.94490 0.94830 0.04430 0.04250 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 443564 20 30202 7696 466090 345999 23557 82348 8340 443564 376445 9668 -38196 1918 345999 0.33000 0.09000 0.58000 0 0 0 956894 1193710 -236816 21707 21707 -215109 978601 21707 21707 956894 0 956894 1193710 0 1193710 0 1193710 DESCRIPTION OF INTENDED USE OF ENDOWMENT FUNDS: PART V, LINE 4: THE TEMPORARILY RESTRICTED FUNDS ARE RESTRICTED BY THE DONOR AND ARE RELEASED FROM RESTRICTION UPON SATISFACTION OF THE RESTRICTION BY THE SOCIETY. THE PERMANENTLY RESTRICTED FUNDS ARE RESTRICTED IN PERPETUITY BY THE DONOR. EARNINGS ON THE FUNDS ARE THEN RESTRICTED FOR THE PURPOSE DESIGNATED BY THE DONOR AND ARE RELEASED FROM RESTRICTION UPON SATISFACTION OF THE RESTRICTION BY THE SOCIETY. 1 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTS TO RECIPIENTS 1140 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS 3050 SOUTH ASIA 0 0 GRANTS TO RECIPIENTS 3350 SUB-SAHARAN AFRICA 0 0 GRANTS TO RECIPIENTS 2460 0 0 0 10000 0 10000 TRAVEL GRANT EUROPE (INCLUDING ICELAND & GREENLAND) 5 3050 CHECK OR WIRE TRANSFER TRAVEL GRANT MIDDLE EAST AND NORTH AFRICA 2 1140 CHECK OR WIRE TRANSFER 0 TRAVEL GRANT SOUTH ASIA 3 3350 CHECK OR WIRE TRANSFER 0 TRAVEL GRANT SUB-SAHARAN AFRICA 1 2460 CHECK OR WIRE TRANSFER 0 0 0 0 0 0 0 PROCEDURE FOR MONITORING GRANTS OUTSIDE THE U.S.: SCHEDULE F, PART I, LINE 2: TRAVEL GRANT RECIPIENTS HAVE TO APPLY AND THE MEMBERSHIP COMMITTEE MAKES THE DECISION ON WHOM TO AWARD THE TRAVEL GRANTS TO. THE AWARDS ARE MONITORED BY THE STAFF OF ISSX. IF A RECIPIENT IS FOUND TO NOT HAVE FULFILLED THE ELIGIBILITY CRITERIA, THE AWARD WILL BE CANCELLED AND/OR FORFEITED. FORM 990, PART VI, SECTION A, LINE 3 THE SOCIETY HAS CONTRACTED WITH SMITHBUCKLIN TO PERFORM ALL MANAGEMENT FUNCTIONS. FORM 990, PART VI, SECTION A, LINE 6 ISSX IS A MEMBERSHIP ORGANIZATION FOR ANYONE ENGAGED IN RESEARCH IN XENOBIOTICS, OR IN THE ADMINISTRATION AND/OR REGULATION OF SUCH RESEARCH, OR ANYONE WHO EXPRESSES A SCIENTIFIC INTEREST IN THE FIELD WILL BE ELIGIBLE FOR MEMBERSHIP. THERE WILL BE NO RESTRICTIONS BECAUSE OF PLACE OF BIRTH, RESIDENCE, NATIONALITY, SEX, RACE OR CREED. MEMBERSHIP CATEGORIES ARE SET FORTH IN THE BY-LAWS. FORM 990, PART VI, SECTION A, LINE 7A ELECTED COUNCILORS: THERE SHALL BE A MINIMUM OF THREE (3) AND MAXIMUM OF ELEVEN (11) COUNCILORS WITH THE ACTUAL NUMBER OF COUNCILORS TO BE DETERMINED BY THE COUNCIL THROUGH A COUNCIL RESOLUTION. SEVEN COUNCILORS SHALL BE ELECTED ON A BIENNIAL BASIS TO SERVE 2-YEAR TERMS. COUNCILORS MAY SERVE NO MORE THAN TWO SUCCESSIVE 2-YEAR TERMS BUT MAY SERVE ADDITIONAL TERMS AFTER AN ABSENCE FROM COUNCIL MEMBERSHIP OF AT LEAST 1 YEAR. FORM 990, PART VI, SECTION B, LINE 11 THE CLIENT MANAGER PERFORMS AN INITIAL REVIEW AND THE EXECUTIVE DIRECTOR PERFORMS A FINAL REVIEW BEFORE EMAILING A COPY TO THE COUNCIL PRIOR TO FILING. FORM 990, PART VI, SECTION B, LINE 12C IN CONNECTION WITH ANY ACTUAL OR POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO DISCLOSE ALL MATERIAL FACTS TO THE COUNCIL MEMBERS AND MEMBERS OF COMMITTEES WITH GOVERNING BOARD DELEGATED POWERS CONSIDERING THE PROPOSED TRANSACTION OR ARRANGEMENT. THE REMAINING COUNCIL MEMBERS SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, HE/SHE SHALL LEAVE THE COUNCIL MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. FORM 990, PART VI, SECTION C, LINE 19 THE GOVERNING DOCUMENTS, POLICIES, AND FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: NET UNREALIZED GAINS ON INVESTMENTS: 21,707. OVERSIGHT OF AUDITOR FORM 990, PART XII, LINE 2C THE SOCIETY HAS AN AUDIT COMMITTEE WHICH ASSUMES RESPONSIBILITY FOR OVERSIGHT AND SELECTION OF THE INDEPENDENT AUDITOR.